View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Asthma News

SPONSORED CONTENT
September 19, 2024
4 min read
Save
Most patients stick with at-home FeNO measurement regimen

Most patients stick with at-home FeNO measurement regimen

Patients with different asthma severity regularly used a home device for measuring fractional exhaled nitric oxide for 12 weeks as part of their asthma management strategies, according to a poster presentation here.

SPONSORED CONTENT
September 19, 2024
3 min read
Save

Greenhouse gas emissions higher with metered-dose vs. dry-powder, soft-mist inhalers

Greenhouse gas emissions higher with metered-dose vs. dry-powder, soft-mist inhalers

Metered-dose inhalers had higher estimated greenhouse gas emissions than dry-powder and soft-mist inhalers but cost less than these propellant-free inhalers, according to a research letter published in JAMA.

SPONSORED CONTENT
September 19, 2024
3 min read
Save

Gum bleeding raises odds for asthma symptoms, COPD 10 years later

Gum bleeding raises odds for asthma symptoms, COPD 10 years later

Odds for asthma symptoms, COPD and chronic bronchitis went up if individuals reported earlier “often/always” vs. “never” gum bleeding, according to a poster presented at the European Respiratory Society International Congress.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
September 18, 2024
5 min read
Save

Cockroach, mouse allergens drive upper respiratory infections in children with asthma

Cockroach, mouse allergens drive upper respiratory infections in children with asthma

Risks for respiratory viral infections increased among children with asthma who were exposed to high levels of floor cockroach and mouse airborne allergens, according to a study published in The Journal of Allergy and Clinical Immunology.

SPONSORED CONTENT
September 18, 2024
4 min read
Save

Airway resistance improves after periodontal treatment

Airway resistance improves after periodontal treatment

The next time you have patients who struggle with airway resistance, you may want to refer them to your local periodontist for a deep cleaning, according to a poster presented at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 17, 2024
3 min read
Save

Asthma, metabolic syndrome worsen COVID-19 outcomes

Asthma, metabolic syndrome worsen COVID-19 outcomes

Asthma increased the need for respiratory support in COVID-19 patients, whereas metabolic syndrome raised the risk for severe COVID-19, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

SPONSORED CONTENT
September 17, 2024
2 min read
Save

Text message reminders improve inhaler adherence in asthma, COPD

Text message reminders improve inhaler adherence in asthma, COPD

Adults with asthma and/or COPD who received 23 text messages about preventer inhaler use over 26 weeks had improved inhaler adherence, according to a poster presented at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 16, 2024
3 min read
Save

Inflammation, mucus plugging improve by 4 weeks with dupilumab

Inflammation, mucus plugging improve by 4 weeks with dupilumab

Patients with asthma on dupilumab saw reduced airway inflammation and mucus plugging beginning at 4 weeks with steady improvements through 24 weeks, according to a study presented at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 16, 2024
3 min read
Save

Patients with asthma, obesity experience improved control with GLP-1 RAs

Patients with asthma, obesity experience improved control with GLP-1 RAs

Patients with asthma who used a glucagon-like peptide 1 receptor agonist for weight loss experienced improved asthma control, according to a poster presented at the European Respiratory Society International Congress.

SPONSORED CONTENT
September 13, 2024
6 min read
Save

Depemokimab reduces severe asthma exacerbations by half with twice-yearly treatment

Depemokimab reduces severe asthma exacerbations by half with twice-yearly treatment

Patients with severe eosinophilic asthma who used depemokimab administered every 6 months experienced a 54% reduction in exacerbations over 52 weeks, according to a study presented at the European Respiratory Society International Congress.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails